The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...
Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...
Distractify on MSN1d
Why Does Seal Have Scars? Details on What Happened to His Face and HairWhy does Seal have scars? The singer's facial scars and bumps are caused by a skin condition. Learn what happened to his face ...
The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...
We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...
Topical mupirocin helps reduce inflammation in lupus, offering a potential new approach for managing symptoms and improving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback